Skip to main content
. 2020 Aug 12;9(8):1892. doi: 10.3390/cells9081892

Figure 6.

Figure 6

This illustration represents a proposed model of metabolic inflammation in support of the data presented, wherein RIH or glucose fluctuations in vitro upregulate the expression of TLR4-IRF5 together with markers of inflammation and the cardiovascular disease marker MMP-9 in macrophages. These data support the notion that controlling glucose fluctuations and/or IRF5 silencing could be beneficial to alleviate metabolic inflammation.